Immunotherapeutic Targeting of Allergic Disease

E-ISSN： 2212-4055|5|4|243-252

ISSN： 1871-5281

Source： Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol.5, Iss.4, 2006-12, pp. : 243-252

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The immunotherapeutic vaccine CAD 106 for use in Alzheimer's disease

Inpharma, Vol. 1, Iss. 1651, 2008-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Targeting Chemoattractant Receptors in Allergic Inflammation

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 2, 2005-04 ,pp. : 163-167

Bentham Science Publishers

Access to resources Recommend Favorite

Immunotherapeutic approaches in prion disease: progress, challenges and potential directions

By Brazier Marcus W Mot Alexandra I White Anthony R Collins Steven J

Therapeutic Delivery, Vol. 4, Iss. 5, 2013-05 ,pp. : 615-628

Future Science

Access to resources Recommend Favorite

Immunotherapy approach to allergic disease

By Fick R.B. Fox J.A. Jardieu P.M.

Immunopharmacology, Vol. 48, Iss. 3, 2000-07 ,pp. : 307-310

Elsevier

Access to resources Recommend Favorite

Olopatadine: a drug for allergic conjunctivitis targeting the mast cell

By Leonardi Andrea Quintieri Luigi

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 6, 2010-04 ,pp. : 969-981

Informa Healthcare

Access to resources Recommend Favorite